Psychosocial Factors in Diabetes and Cardiovascular Risk

Current Cardiology Reports

Volumn 18, Issue 10, 2016, Pages

  Hackett, Ruth A ^a   Steptoe, Andrew ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Cardiovascular disease; Depression; Psychosocial factors; Stress; Type 2 diabetes

Indexed keywords

HEMOGLOBIN A1C;

ANXIETY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; COMORBIDITY; DEPRESSION; DISTRESS SYNDROME; EARLY LIFE STRESS; EMOTIONAL STRESS; GLYCEMIC CONTROL; HEART INFARCTION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; ISCHEMIC HEART DISEASE; JOB STRESS; LIFE STRESS; LIFESTYLE MODIFICATION; MENTAL STRESS; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; PERSONALITY; PRENATAL STRESS; PSYCHOLOGICAL WELL-BEING; REVIEW; SOCIOECONOMICS; ATTITUDE TO HEALTH; COMPLICATION; COPING BEHAVIOR; DIABETIC ANGIOPATHIES; PATHOPHYSIOLOGY; PSYCHOLOGY; RISK FACTOR;

ADAPTATION, PSYCHOLOGICAL; COMORBIDITY; DEPRESSION; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; PERSONALITY; RISK FACTORS; STRESS, PSYCHOLOGICAL;

EID: 84983747542     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-016-0771-4     Document Type: Review

References (121)

1. International Diabetes Federation. IDF diabetes atlas. 7th ed. Brussels: International Diabetes Federation; 2015.
2. World Health Organization. Global report on diabetes. Geneva: World Health Organization; 2016.
3. Centers for Disease Control and Prevention. National diabetes statistics report: estimates of diabetes and its burden in the United States, 2014. Atlanta: Department of Health and Human Services; 2014.
4. Holman N, Young B, Gadsby R. Current prevalence of type 1 and type 2 diabetes in adults and children in the UK. Diabet Med. 2015;32:1119–20.
5. WHO. Global status report on non-communicable disease 2010. Geneva: World Health Organization; 2011.
6. Seuring T, Archangelidi O, Suhrcke M. The economic costs of type 2 diabetes: a global systematic review. PharmacoEconomics. 2015;33:811–31.
7. Emerging Risk Factors Collaboration, Sarwar N, Gao P, Seshasai SRK, Gobin R, Kaptoge S, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375:2215–22.
8. Ford ES, Zhao G, Li C. Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidence. J Am Coll Cardiol. 2010;55:1310–7.
9. Shah AD, Langenberg C, Rapsomaniki E, Denaxas S, Pujades-Rodriguez M, Gale CP, et al. Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people. Lancet Diabetes Endocrinol. 2015;3:105–13.
10. Barengo NC, Katoh S, Moltchanov V, Tajima N, Tuomilehto J. The diabetes-cardiovascular risk paradox: results from a Finnish population-based prospective study. Eur Heart J. 2008;29:1889–95.
11. Fox CS, Golden SH, Anderson C, Bray GA, Burke LE, de Boer IH, et al. Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care. 2015;38:1777–803. An informative overview of lifestyle trials to prevent CVD in people with diabetes.
12. Gore MO, Patel MJ, Kosiborod M, Parsons LS, Khera A, de Lemos JA, et al. Diabetes mellitus and trends in hospital survival after myocardial infarction, 1994 to 2006: data from the national registry of myocardial infarction. Circ Cardiovasc Qual Outcomes. 2012;5:791–7.
13. Emerging Risk Factors Collaboration. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011;364:829–41.
14. The Emerging Risk Factors Collaboration. Association of cardiometabolic multimorbidity with mortality. JAMA. 2015;314:52–60.
15. Wiviott SD, Braunwald E, Angiolillo DJ, Meisel S, Dalby AJ, Verheugt FWA, et al. Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel–thrombolysis in myocardial infarction 38. Circulation. 2008;118:1626–36.
16. MacDonald MR, Petrie MC, Varyani F, Östergren J, Michelson EL, Young JB, et al. Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme. Eur Heart J. 2008;29:1377–85.
17. van Wijk I, Kappelle L, van Gijn J, Koudstaal P, Franke C, Vermeulen M, et al. Long-term survival and vascular event risk after transient ischaemic attack or minor ischaemic stroke: a cohort study. The Lancet. 2005;365:2098–104.
18. Newman GC, Bang H, Hussain SI, Toole JF. Association of diabetes, homocysteine, and HDL with cognition and disability after stroke. Neurology. 2007;69:2054–62.
19. Hlatky MA, Boothroyd DB, Bravata DM, Boersma E, Booth J, Brooks MM, et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. The Lancet. 2009;373:1190–7.
20. Kuchulakanti PK, Chu WW, Torguson R, Ohlmann P, Rha S-W, Clavijo LC, et al. Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents. Circulation. 2006;113:1108–13.
21. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937–52.
22. Gore MO, McGuire DK, Lingvay I, Rosenstock J. Predicting cardiovascular risk in type 2 diabetes: the heterogeneity challenges. Curr Cardiol Rep. 2015;17:607.
23. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403.
24. Uusitupa M, Peltonen M, Lindström J, Aunola S, Ilanne-Parikka P, Keinänen-Kiukaanniemi S, et al. Ten-year mortality and cardiovascular morbidity in the Finnish Diabetes Prevention Study—secondary analysis of the randomized trial. PLoS One. 2009;4, e5656.
25. Li G, Zhang P, Wang J, Gregg EW, Yang W, Gong Q, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet Lond Engl. 2008;371:1783–9.
26. Look AHEAD Research Group, Wing RR, Bolin P, Brancati FL, Bray GA, Clark JM, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369:145–54.
27. ACCORD Study Group, Cushman WC, Evans GW, Byington RP, Goff DC, Grimm RH, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010;362:1575–85.
28. Ginsberg HN. The ACCORD (Action to Control Cardiovascular Risk in Diabetes) lipid trial: what we learn from subgroup analyses. Diabetes Care. 2011;34:S107–8.
29. Koivula RW, Tornberg AB, Franks PW. Exercise and diabetes-related cardiovascular disease: systematic review of published evidence from observational studies and clinical trials. Curr Diab Rep. 2013;13:372–80.
30. Estruch R, Ros E, Salas-Salvadó J, Covas M-I, Corella D, Arós F, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013;368:1279–90.
31. Dimsdale JE. Psychological stress and cardiovascular disease. J Am Coll Cardiol. 2008;51:1237–46.
32. Hjemdahl P, Rosengren A, Steptoe A. Stress and cardiovascular. New York: Springer; 2012.
33. Steptoe A, Kivimäki M. Stress and cardiovascular disease: an update on current knowledge. Annu Rev Public Health. 2013;34:337–54. A substantial review of the involvement of psychosocial stress factors in CVD.
34. Everson-Rose SA, Lewis TT. Psychosocial factors and cardiovascular diseases. Annu Rev Public Health. 2005;26:469–500.
35. Kuper H, Marmot M, Hemingway H. Systematic review of prospective cohort studies of psychosocial factors in the etiology and prognosis of coronary heart disease. Semin Vasc Med. 2002;2:267–314.
36. Knol MJ, Twisk JWR, Beekman ATF, Heine RJ, Snoek FJ, Pouwer F. Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia. 2006;49:837–45.
37. Mezuk B, Eaton WW, Albrecht S, Golden SH. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care. 2008;31:2383–90.
38. Demakakos P, Zaninotto P, Nouwen A. Is the association between depressive symptoms and glucose metabolism bidirectional? Evidence from the English Longitudinal Study of Ageing. Psychosom Med. 2014;76:555–61.
39. Pan A, Lucas M, Sun Q, van Dam RM, Franco OH, Manson JE, et al. Bidirectional association between depression and type 2 diabetes mellitus in women. Arch Intern Med. 2010;170:1884–91.
40. Tabák AG, Akbaraly TN, Batty GD, Kivimäki M. Depression and type 2 diabetes: a causal association? Lancet Diabetes Endocrinol. 2014;2:236–45. A thoughtful review of the evidence for a casual association between diabetes and depression.
41. Engum A. The role of depression and anxiety in onset of diabetes in a large population-based study. J Psychosom Res. 2007;62:31–8.
42. Atlantis E, Vogelzangs N, Cashman K, Penninx BJWH. Common mental disorders associated with 2-year diabetes incidence: the Netherlands Study of Depression and Anxiety (NESDA). J Affect Disord. 2012;142(Suppl):S30–5.
43. Abraham S, Shah NG, Roux AD, Hill-Briggs F, Seeman T, Szklo M, et al. Trait anger but not anxiety predicts incident type 2 diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA). Psychoneuroendocrinology. 2015;60:105–13.
44. Edwards LE, Mezuk B. Anxiety and risk of type 2 diabetes: evidence from the Baltimore Epidemiologic Catchment Area Study. J Psychosom Res. 2012;73:418–23.
45. Farvid MS, Qi L, Hu FB, Kawachi I, Okereke OI, Kubzansky LD, et al. Phobic anxiety symptom scores and incidence of type 2 diabetes in US men and women. Brain Behav Immun. 2014;36:176–82.
46. Demmer RT, Gelb S, Suglia SF, Keyes KM, Aiello AE, Colombo PC, et al. Sex differences in the association between depression, anxiety, and type 2 diabetes mellitus. Psychosom Med. 2015;77:467–77.
47. Mommersteeg PM, Herr R, Zijlstra WP, Schneider S, Pouwer F. Higher levels of psychological distress are associated with a higher risk of incident diabetes during 18 year follow-up: results from the British household panel survey. BMC Public Health. 2012;12:1109.
48. Virtanen M, Ferrie JE, Tabak AG, Akbaraly TN, Vahtera J, Singh-Manoux A, et al. Psychological distress and incidence of type 2 diabetes in high-risk and low-risk populations: the Whitehall II cohort study. Diabetes Care. 2014;37:2091–7.
49. Eriksson A-K, Ekbom A, Granath F, Hilding A, Efendic S, Ostenson C-G. Psychological distress and risk of pre-diabetes and type 2 diabetes in a prospective study of Swedish middle-aged men and women. Diabet Med J Br Diabet Assoc. 2008;25:834–42.
50. Kivimäki M, Virtanen M, Kawachi I, Nyberg ST, Alfredsson L, Batty GD, et al. Long working hours, socioeconomic status, and the risk of incident type 2 diabetes: a meta-analysis of published and unpublished data from 222 120 individuals. Lancet Diabetes Endocrinol. 2015;3:27–34.
51. Nyberg ST, Fransson EI, Heikkilä K, Ahola K, Alfredsson L, Bjorner JB, et al. Job strain as a risk factor for type 2 diabetes: a pooled analysis of 124,808 men and women. Diabetes Care. 2014;37:2268–75. A large analysis associating work stress with future diabetes onset.
52. Karasek RA, Theorell T. Healthy work. New York: Basic Books; 1990.
53. Nyberg ST, Fransson EI, Heikkilä K, Alfredsson L, Casini A, Clays E, et al. Job strain and cardiovascular disease risk factors: meta-analysis of individual-participant data from 47,000 men and women. PLoS One. 2013;8, e67323.
54. Novak M, Björck L, Giang KW, Heden-Ståhl C, Wilhelmsen L, Rosengren A. Perceived stress and incidence of type 2 diabetes: a 35-year follow-up study of middle-aged Swedish men. Diabet Med J Br Diabet Assoc. 2013;30:e8–e16.
55. Toshihiro M, Saito K, Takikawa S, Takebe N, Onoda T, Satoh J. Psychosocial factors are independent risk factors for the development of type 2 diabetes in Japanese workers with impaired fasting glucose and/or impaired glucose tolerance. Diabet Med J Br Diabet Assoc. 2008;25:1211–7.
56. Rod NH, Grønbæk M, Schnohr P, Prescott E, Kristensen TS. Perceived stress as a risk factor for changes in health behaviour and cardiac risk profile: a longitudinal study. J Intern Med. 2009;266:467–75.
57. Williams ED, Magliano DJ, Tapp RJ, Oldenburg BF, Shaw JE. Psychosocial stress predicts abnormal glucose metabolism: the Australian Diabetes, Obesity and Lifestyle (AusDiab) study. Ann Behav Med Publ Soc Behav Med. 2013;46:62–72.
58. Kato M, Noda M, Inoue M, Kadowaki T, Tsugane S, JPHC Study Group. Psychological factors, coffee and risk of diabetes mellitus among middle-aged Japanese: a population-based prospective study in the JPHC study cohort. Endocr J. 2009;56:459–68.
59. Wiernik E, Nabi H, Thomas F, Pannier B, Hanon O, Simon T, et al. Association between current perceived stress and incident diabetes is dependent on occupational status: evidence from the IPC cohort study. Diabetes Metab. 2016. doi:10.1016/j.diabet.2016.01.004.
60. Price LH, Kao H-T, Burgers DE, Carpenter LL, Tyrka AR. Telomeres and early-life stress: an overview. Biol Psychiatry. 2013;73:15–23.
61. Danese A, Caspi A, Williams B, Ambler A, Sugden K, Mika J, et al. Biological embedding of stress through inflammation processes in childhood. Mol Psychiatry. 2011;16:244–6.
62. Huang H, Yan P, Shan Z, Chen S, Li M, Luo C, et al. Adverse childhood experiences and risk of type 2 diabetes: a systematic review and meta-analysis. Metabolism. 2015;64:1408–18. An interesting review of evidence linking early life adversity and diabetes.
63. Virk J, Li J, Vestergaard M, Obel C, Kristensen JK, Olsen J. Prenatal exposure to bereavement and type-2 diabetes: a Danish longitudinal population based study. PLoS One. 2012;7, e43508.
64. Cook WW, Medley DM. Proposed hostility and pharisaic-virtue scales for the MMPI. J Appl Psychol. 1954;38:414.
65. Shen B-J, Countryman AJ, Spiro A, Niaura R. The prospective contribution of hostility characteristics to high fasting glucose levels. Diabetes Care. 2008;31:1293–8.
66. Suarez EC. Sex differences in the relation of depressive symptoms, hostility, and anger expression to indices of glucose metabolism in nondiabetic adults. Health Psychol Off J Div Health Psychol Am Psychol Assoc. 2006;25:484–92.
67. Zhang J, Niaura R, Dyer JR, Shen B-J, Todaro JF, McCaffery JM, et al. Hostility and urine norepinephrine interact to predict insulin resistance: the VA normative aging study. Psychosom Med. 2006;68:718–26.
68. Kawakami N, Araki S, Ohtsu H, Hayashi T, Masumoto T, Yokoyama K. Effects of mood states, smoking and urinary catecholamine excretion on hemoglobin A1c in male Japanese workers. Ind Health. 1995;33:153–62.
69. Williams ED, Steptoe A, Chambers JC, Kooner JS. Ethnic and gender differences in the relationship between hostility and metabolic and autonomic risk factors for coronary heart disease. Psychosom Med. 2011;73:53–8.
70. Golden SH, Williams JE, Ford DE, Yeh H-C, Sanford CP, Nieto FJ, et al. Anger temperament is modestly associated with the risk of type 2 diabetes mellitus: the atheroslcerosis risk in communities study. Psychoneuroendocrinology. 2006;31:325–32.
71. Crump C, Sundquist J, Winkleby MA, Sundquist K. Stress resilience and subsequent risk of type 2 diabetes in 1.5 million young men. Diabetologia. 2016;1–6. A novel study of stress resilience and future diabetes risk in a large Swedish cohort.
72. Boehm JK, Trudel-Fitzgerald C, Kivimaki M, Kubzansky LD. The prospective association between positive psychological well-being and diabetes. Health Psychol. 2015;34:1013–21.
73. Mommersteeg PMC, Herr R, Pouwer F, Holt RIG, Loerbroks A. The association between diabetes and an episode of depressive symptoms in the 2002 World Health Survey: an analysis of 231,797 individuals from 47 countries. Diabet Med J Br Diabet Assoc. 2013;30:e208–14.
74. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001;24:1069–78.
75. Ali S, Stone MA, Peters JL, Davies MJ, Khunti K. The prevalence of co-morbid depression in adults with type 2 diabetes: a systematic review and meta-analysis. Diabet Med J Br Diabet Assoc. 2006;23:1165–73.
76. Roy T, Lloyd CE. Epidemiology of depression and diabetes: a systematic review. J Affect Disord. 2012;142(Suppl):S8–S21.
77. Nouwen A, Winkley K, Twisk J, Lloyd CE, Peyrot M, Ismail K, et al. Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis. Diabetologia. 2010;53:2480–6.
78. Rotella F, Mannucci E. Diabetes mellitus as a risk factor for depression. A meta-analysis of longitudinal studies. Diabetes Res Clin Pract. 2013;99:98–104.
79. Browne JL, Nefs G, Pouwer F, Speight J. Depression, anxiety and self-care behaviours of young adults with type 2 diabetes: results from the International Diabetes Management and Impact for Long-term Empowerment and Success (MILES) Study. Diabet Med J Br Diabet Assoc. 2015;32:133–40.
80. O’Neil A, Williams ED, Browne JL, Horne R, Pouwer F, Speight J. Associations between economic hardship and markers of self-management in adults with type 2 diabetes: results from Diabetes MILES – Australia. Aust N Z J Public Health. 2014;38:466–72.
81. Huang C-Q, Dong B-R, Lu Z-C, Yue J-R, Liu Q-X. Chronic diseases and risk for depression in old age: a meta-analysis of published literature. Ageing Res Rev. 2010;9:131–41.
82. Wikman A, Wardle J, Steptoe A. Quality of life and affective well-being in middle-aged and older people with chronic medical illnesses: a cross-sectional population based study. PLoS One. 2011;6, e18952.
83. Ali S, Stone M, Skinner TC, Robertson N, Davies M, Khunti K. The association between depression and health-related quality of life in people with type 2 diabetes: a systematic literature review. Diabetes Metab Res Rev. 2010;26:75–89.
84. Schram MT, Baan CA, Pouwer F. Depression and quality of life in patients with diabetes: a systematic review from the European depression in diabetes (EDID) research consortium. Curr Diabetes Rev. 2009;5:112–9.
85. Rush WA, Whitebird RR, Rush MR, Solberg LI, O’Connor PJ. Depression in patients with diabetes: does it impact clinical goals? J Am Board Fam Med. 2008;21:392–7.
86. Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care. 2000;23:934–42.
87. Gonzalez JS, Peyrot M, McCarl LA, Collins EM, Serpa L, Mimiaga MJ, et al. Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care. 2008;31:2398–403.
88. Katon WJ, Russo JE, Heckbert SR, Lin EHB, Ciechanowski P, Ludman E, et al. The relationship between changes in depression symptoms and changes in health risk behaviors in patients with diabetes. Int J Geriatr Psychiatry. 2010;25:466–75.
89. Sieu N, Katon W, Lin EHB, Russo J, Ludman E, Ciechanowski P. Depression and incident diabetic retinopathy: a prospective cohort study. Gen Hosp Psychiatry. 2011;33:429–35.
90. Williams LH, Rutter CM, Katon WJ, Reiber GE, Ciechanowski P, Heckbert SR, et al. Depression and incident diabetic foot ulcers: a prospective cohort study. Am J Med. 2010;123:748–54.
91. Black SA, Markides KS, Ray LA. Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes. Diabetes Care. 2003;26:2822–8.
92. Lin EHB, Rutter CM, Katon W, Heckbert SR, Ciechanowski P, Oliver MM, et al. Depression and advanced complications of diabetes: a prospective cohort study. Diabetes Care. 2010;33:264–9.
93. Scherrer JF, Garfield LD, Chrusciel T, Hauptman PJ, Carney RM, Freedland KE, et al. Increased risk of myocardial infarction in depressed patients with type 2 diabetes. Diabetes Care. 2011;34:1729–34.
94. Cummings DM, Kirian K, Howard G, Howard V, Yuan Y, Muntner P, et al. Consequences of comorbidity of elevated stress and/or depressive symptoms and incident cardiovascular outcomes in diabetes: results from the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. Diabetes Care. 2016;39:101–9.
95. Ting RZW, Lau ESH, Ozaki R, Lau WWY, Kong APS, Luk AOY, et al. High risk for cardiovascular disease in Chinese type 2 diabetic patients with major depression—a 7-year prospective analysis of the Hong Kong Diabetes Registry. J Affect Disord. 2013;149:129–35. A novel study of depression and diabetes in relation to CVD in a Chinese cohort.
96. Smith KJ, Béland M, Clyde M, Gariépy G, Pagé V, Badawi G, et al. Association of diabetes with anxiety: a systematic review and meta-analysis. J Psychosom Res. 2013;74:89–99.
97. Anderson RJ, Grigsby AB, Freedland KE, de Groot M, McGill JB, Clouse RE, et al. Anxiety and poor glycemic control: a meta-analytic review of the literature. Int J Psychiatry Med. 2002;32:235–47.
98. Dalsgaard E-M, Vestergaard M, Skriver MV, Maindal HT, Lauritzen T, Borch-Johnsen K, et al. Psychological distress, cardiovascular complications and mortality among people with screen-detected type 2 diabetes: follow-up of the ADDITION-Denmark trial. Diabetologia. 2014;57:710–7.
99. Fisher L, Skaff MM, Mullan JT, Arean P, Mohr D, Masharani U, et al. Clinical depression versus distress among patients with type 2 diabetes: not just a question of semantics. Diabetes Care. 2007;30:542–8.
100. TM): cross-national benchmarking of diabetes-related psychosocial outcomes for people with diabetes. Diabet Med. 2013;30:767–77.
101. Aikens JE. Prospective associations between emotional distress and poor outcomes in type 2 diabetes. Diabetes Care. 2012;35:2472–8.
102. Fisher L, Mullan JT, Arean P, Glasgow RE, Hessler D, Masharani U. Diabetes distress but not clinical depression or depressive symptoms is associated with glycemic control in both cross-sectional and longitudinal analyses. Diabetes Care. 2010;33:23–8.
103. Koopmans B, Pouwer F, de Bie RA, van Rooij ES, Leusink GL, Pop VJ. Depressive symptoms are associated with physical inactivity in patients with type 2 diabetes. The DIAZOB Primary Care Diabetes study. Fam Pract. 2009;26:171–3.
104. Collins MM, Corcoran P, Perry IJ. Anxiety and depression symptoms in patients with diabetes. Diabet Med. 2009;26:153–61.
105. Goff DC, Gerstein HC, Ginsberg HN, Cushman WC, Margolis KL, Byington RP, et al. Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol. 2007;99:4i–20i.
106. McEwen BS. Protective and damaging effects of stress mediators. N Engl J Med. 1998;338:171–9.
107. Steptoe A, Hackett RA, Lazzarino AI, Bostock S, La Marca R, Hamer M, et al. Disruption of multisystem responses to stress in type 2 diabetes: investigating the dynamics of allostatic load. Proc Natl Acad Sci U S A. 2014;111:15693–8. The first laboratory stress trial to compare dynamic stress responses in people with diabetes and healthy controls.
108. Hackett RA, Lazzarino AI, Carvalho LA, Hamer M, Steptoe A. Hostility and physiological responses to acute stress in people with type 2 diabetes. Psychosom Med. 2015;77:458–66.
109. Adam EK, Hawkley LC, Kudielka BM, Cacioppo JT. Day-to-day dynamics of experience—cortisol associations in a population-based sample of older adults. Proc Natl Acad Sci U S A. 2006;103:17058–63.
110. Kumari M, Shipley M, Stafford M, Kivimaki M. Association of diurnal patterns in salivary cortisol with all-cause and cardiovascular mortality: findings from the Whitehall II study. J Clin Endocrinol Metab. 2011;96:1478–85.
111. Hackett RA, Kivimäki M, Kumari M, Steptoe A. Diurnal cortisol patterns, future diabetes, and impaired glucose metabolism in the Whitehall II cohort study. J Clin Endocrinol Metab. 2016;101:619–25.
112. Hänsel A, Hong S, Cámara RJA, von Känel R. Inflammation as a psychophysiological biomarker in chronic psychosocial stress. Neurosci Biobehav Rev. 2010;35:115–21.
113. Akash MSH, Rehman K, Chen S. Role of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitus. J Cell Biochem. 2013;114:525–31.
114. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685–95.
115. Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011;473:317–25.
116. Baumeister H, Hutter N, Bengel J. Psychological and pharmacological interventions for depression in patients with diabetes mellitus and depression. Cochrane Database Syst Rev. 2012;12, CD008381.
117. Noordali F, Cumming J, Thompson JL. Effectiveness of mindfulness-based interventions on physiological and psychological complications in adults with diabetes: a systematic review. J. Health Psychol. 2015;1359105315620293. An exploratory review of mindfulness-based interventions in people with diabetes.
118. Adriaanse MC, Pouwer F. Diabetes, depression, and cardiovascular risk. The handbook of psychocardiology. Singapore: Springer; 2015.
119. Bogner HR, Morales KH, Post EP, Bruce ML. Diabetes, depression, and death: a randomized controlled trial of a depression treatment program for older adults based in primary care (PROSPECT). Diabetes Care. 2007;30:3005–10.
120. Thombs BD, Ziegelstein RC. Diabetes, depression, and death: a randomized controlled trial of a depression treatment program for older adults based in primary care (PROSPECT). Diabetes Care. 2008;30:3005–10.
121. Jones A, Vallis M, Pouwer F. If it does not significantly change HbA1c levels why should we waste time on it? A plea for the prioritization of psychological well-being in people with diabetes. Diabet Med. 2015;32:155–63.